"NASH Centric Transaction"

  1. 327 Posts.
    lightbulb Created with Sketch.  7
    On p. 34 of the latest, post-results presentation, the company now lists a "NASH Centric Transaction" as a value driver in 2018 (separately from the Pediatric NAFLD Phase 2 topline results in 4Q/2018 and ASH Phase 2 results in 1Q/2019).

    "NASH Centric Transaction." Sure sounds like partnership talk to me.

    Company also expects results from colitis pre-clinical studies and US Army and US Navy Travelan trial results in 2018.

    http://www.immuron.com/assets/Uploads/Immuron-Corporate-Presentation-March-2018-V4.pdf
    Last edited by Orioles: 27/03/18
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $10.45M
Open High Low Volume
0.0¢ 0.0¢ 0.0¢ 0

Buyers (Bids)

Vol. Price($)
57122 3.3¢
 

Sellers (Offers)

Price($) Vol.
3.6¢ 39734
Last trade - 11.13am 07/08/2026 (20 minute delay) ?
IMC (ASX) Chart
Day chart unavailable
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.